Skip to main content
Wed, Apr 8, 2026
S&P 500 5,142.30 +0.87%|NASDAQ 16,284.75 +1.12%|DOW 38,972.10 -0.23%|AAPL $192.45 +1.80%|TSLA $241.80 -2.10%|AMZN $178.92 +0.54%|GOOGL $141.20 +0.32%|MSFT $415.60 -0.15%|
S&P 500 5,142.30 +0.87%|NASDAQ 16,284.75 +1.12%|DOW 38,972.10 -0.23%|AAPL $192.45 +1.80%|TSLA $241.80 -2.10%|AMZN $178.92 +0.54%|GOOGL $141.20 +0.32%|MSFT $415.60 -0.15%|
Sample data
HealthUnited States1 sourcesNeutral

GPT-4o detects cancer drug adverse events in clinical notes but falls short of decision support threshold

AI models from OpenAI scored below clinical-use thresholds when screening cancer patient records for drug side effects, a multicenter study found. GPT-4o hit F1 scores of 56-66%, well short of the 80% needed for automated decisions.

JE
jeroen erne
via Complete Ai Training
GPT-4o detects cancer drug adverse events in clinical notes but falls short of decision support threshold

Source Verification

Corroboration Score: 1

This story was independently reported by 1 sources. Click any source to read the original article.

Comments

0 comments
Be respectful and constructive.
Loading comments...